Madison WI 伯基特淋巴瘤临床试验
5项针对 伯基特淋巴瘤的研究正在 Madison及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
招募中2 期
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
招募中3 期
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
招募中2 期
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
招募中3 期
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
招募中1/2 期
- University of Wisconsin Carbone Cancer Center, Madison
其他城市的 伯基特淋巴瘤试验
- Houston, TX21 项研究
- Milwaukee, WI16 项研究
- Philadelphia, PA16 项研究
- New York City, NY14 项研究
- Chicago, IL14 项研究
- Cincinnati, OH12 项研究
- Atlanta, GA12 项研究
- Seattle, WA11 项研究
- Durham, NC10 项研究
- Boston, MA10 项研究
- Los Angeles, CA10 项研究
- Aurora, CO10 项研究
Madison的其他研究
- 前列腺癌29 项研究
- 结直肠癌22 项研究
- 乳腺癌22 项研究
- 转移性癌症21 项研究
- 非小细胞肺癌16 项研究
- 急性髓系白血病16 项研究
- 黑色素瘤15 项研究
- 癌症（所有类型）14 项研究
- 卵巢癌13 项研究
- 胃癌11 项研究
- 肺癌10 项研究
- 胰腺癌10 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。